Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank 指定難病告示番号
1 CDK4 6件: PI3K-Akt signaling pathway, Tight junction, T cell receptor signaling pathway, Pathways in cancer, Viral carcinogenesis, Small cell lung cancer D10688 Abemaciclib 1件: 34
2 CDK6 4件: PI3K-Akt signaling pathway, Pathways in cancer, Viral carcinogenesis, Small cell lung cancer D10688 Abemaciclib 1件: 34
3 CSF1R 6件: Ras signaling pathway, Rap1 signaling pathway, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer D08552 Sunitinib 2件: 28, 34
4 CSF1R 6件: Ras signaling pathway, Rap1 signaling pathway, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer D11270 Pexidartinib 1件: 34
5 CSF2RA 1件: Pathways in cancer D05066 Molgramostim 3件: 97, 229, 299
6 CSF2RA 1件: Pathways in cancer D05712 Regramostim 1件: 229
7 CSF2RA 1件: Pathways in cancer D05803 Sargramostim 7件: 6, 28, 60, 62, 96, 229, 285
8 CSF2RA 1件: Pathways in cancer D09930 Mavrilimumab 2件: 41, 46
9 CSF3R 2件: PI3K-Akt signaling pathway, Pathways in cancer D03235 Filgrastim 35件: 2, 6, 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331
10 CSF3R 2件: PI3K-Akt signaling pathway, Pathways in cancer D03247 Lenograstim 7件: 2, 13, 16, 18, 19, 57, 65
11 CSF3R 2件: PI3K-Akt signaling pathway, Pathways in cancer D06889 Pegfilgrastim 1件: 60
12 NQO1 2件: Ubiquinone and other terpenoid-quinone biosynthesis, Pathways in cancer D08682 Warfarin 11件: 6, 8, 13, 19, 46, 49, 66, 85, 86, 88, 91
13 AGTR1 5件: Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D00150 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224
14 AGTR1 5件: Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D00400 Valsartan 7件: 57, 58, 66, 75, 218, 222, 224
15 AGTR1 5件: Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D00522 Candesartan 2件: 58, 67
16 AGTR1 5件: Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D00523 Irbesartan 4件: 66, 167, 168, 222
17 AGTR1 5件: Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D00626 Candesartan cilexetil 1件: 67
18 AGTR1 5件: Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D00627 Telmisartan 2件: 66, 67
19 AGTR1 5件: Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D02014 Angiotensin II 7件: 17, 19, 46, 66, 86, 222, 224
20 AGTR1 5件: Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D08146 Losartan 17件: 17, 19, 36, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299
21 AGTR1 5件: Phospholipase D signaling pathway, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer D11776 Sparsentan 3件: 66, 218, 222
22 EDNRA 3件: Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D01227 Bosentan 10件: 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
23 EDNRA 3件: Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D07077 Ambrisentan 7件: 51, 84, 85, 86, 88, 210, 211
24 EDNRA 3件: Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D07171 Sitaxentan 1件: 86
25 EDNRA 3件: Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D07538 Bosentan 10件: 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
26 EDNRA 3件: Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D07741 Zibotentan 1件: 51
27 EDNRA 3件: Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D10135 Macitentan 5件: 51, 85, 86, 88, 210
28 EDNRA 3件: Vascular smooth muscle contraction, Renin secretion, Pathways in cancer D11776 Sparsentan 3件: 66, 218, 222
29 EDNRB 2件: Relaxin signaling pathway, Pathways in cancer D01227 Bosentan 10件: 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
30 EDNRB 2件: Relaxin signaling pathway, Pathways in cancer D07538 Bosentan 10件: 41, 47, 51, 84, 85, 86, 88, 210, 211, 212
31 EDNRB 2件: Relaxin signaling pathway, Pathways in cancer D10135 Macitentan 5件: 51, 85, 86, 88, 210
32 EGFR 11件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D01977 Gefitinib 1件: 75
33 EGFR 11件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D03455 Cetuximab 2件: 51, 86
34 EGFR 11件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D07907 Erlotinib 1件: 94
35 EGFR 11件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D08108 Lapatinib 3件: 34, 74, 75
36 EGFR 11件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D08950 Neratinib 1件: 34
37 EGFR 11件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11251 Icotinib 1件: 34
38 EGFR 11件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Relaxin signaling pathway, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11772 Tesevatinib 1件: 67
39 EPOR 2件: PI3K-Akt signaling pathway, Pathways in cancer D09946 Peginesatide 1件: 283
40 ERBB2 6件: Platinum drug resistance, PI3K-Akt signaling pathway, Tight junction, Pathways in cancer, Proteoglycans in cancer, Prostate cancer D08108 Lapatinib 3件: 34, 74, 75
41 ERBB2 6件: Platinum drug resistance, PI3K-Akt signaling pathway, Tight junction, Pathways in cancer, Proteoglycans in cancer, Prostate cancer D08950 Neratinib 1件: 34
42 ERBB2 6件: Platinum drug resistance, PI3K-Akt signaling pathway, Tight junction, Pathways in cancer, Proteoglycans in cancer, Prostate cancer D11772 Tesevatinib 1件: 67
43 ESR1 4件: Prolactin signaling pathway, Thyroid hormone signaling pathway, Pathways in cancer, Proteoglycans in cancer D00105 Estradiol 7件: 13, 46, 49, 65, 76, 226, 299
44 ESR1 4件: Prolactin signaling pathway, Thyroid hormone signaling pathway, Pathways in cancer, Proteoglycans in cancer D00185 Estriol 2件: 13, 227
45 ESR1 4件: Prolactin signaling pathway, Thyroid hormone signaling pathway, Pathways in cancer, Proteoglycans in cancer D00289 Danazol 5件: 60, 63, 64, 65, 285
46 ESR1 4件: Prolactin signaling pathway, Thyroid hormone signaling pathway, Pathways in cancer, Proteoglycans in cancer D00554 Ethinylestradiol 4件: 13, 46, 49, 299
47 ESR1 4件: Prolactin signaling pathway, Thyroid hormone signaling pathway, Pathways in cancer, Proteoglycans in cancer D00575 Mestranol 2件: 46, 49
48 ESR1 4件: Prolactin signaling pathway, Thyroid hormone signaling pathway, Pathways in cancer, Proteoglycans in cancer D01161 Fulvestrant 2件: 49, 86
49 ESR1 4件: Prolactin signaling pathway, Thyroid hormone signaling pathway, Pathways in cancer, Proteoglycans in cancer D01413 Estradiol valerate 1件: 65
50 ESR1 4件: Prolactin signaling pathway, Thyroid hormone signaling pathway, Pathways in cancer, Proteoglycans in cancer D01986 Estriol 2件: 13, 227
51 ESR1 4件: Prolactin signaling pathway, Thyroid hormone signaling pathway, Pathways in cancer, Proteoglycans in cancer D02367 Desogestrel 1件: 230
52 ESR1 4件: Prolactin signaling pathway, Thyroid hormone signaling pathway, Pathways in cancer, Proteoglycans in cancer D07726 Clomifene 1件: 74
53 ESR1 4件: Prolactin signaling pathway, Thyroid hormone signaling pathway, Pathways in cancer, Proteoglycans in cancer D08409 Prasterone 6件: 49, 53, 83, 86, 96, 113
54 ESR1 4件: Prolactin signaling pathway, Thyroid hormone signaling pathway, Pathways in cancer, Proteoglycans in cancer D08465 Raloxifene 1件: 46
55 ESR1 4件: Prolactin signaling pathway, Thyroid hormone signaling pathway, Pathways in cancer, Proteoglycans in cancer D08559 Tamoxifen 3件: 2, 113, 227
56 ESR1 4件: Prolactin signaling pathway, Thyroid hormone signaling pathway, Pathways in cancer, Proteoglycans in cancer D11513 Estetrol 1件: 53
57 ESR1 4件: Prolactin signaling pathway, Thyroid hormone signaling pathway, Pathways in cancer, Proteoglycans in cancer D11514 Estetrol 1件: 53
58 ESR2 2件: Prolactin signaling pathway, Pathways in cancer D00105 Estradiol 7件: 13, 46, 49, 65, 76, 226, 299
59 ESR2 2件: Prolactin signaling pathway, Pathways in cancer D00185 Estriol 2件: 13, 227
60 ESR2 2件: Prolactin signaling pathway, Pathways in cancer D00575 Mestranol 2件: 46, 49
61 ESR2 2件: Prolactin signaling pathway, Pathways in cancer D01161 Fulvestrant 2件: 49, 86
62 ESR2 2件: Prolactin signaling pathway, Pathways in cancer D01413 Estradiol valerate 1件: 65
63 ESR2 2件: Prolactin signaling pathway, Pathways in cancer D01986 Estriol 2件: 13, 227
64 ESR2 2件: Prolactin signaling pathway, Pathways in cancer D07726 Clomifene 1件: 74
65 ESR2 2件: Prolactin signaling pathway, Pathways in cancer D08409 Prasterone 6件: 49, 53, 83, 86, 96, 113
66 ESR2 2件: Prolactin signaling pathway, Pathways in cancer D08465 Raloxifene 1件: 46
67 ESR2 2件: Prolactin signaling pathway, Pathways in cancer D08559 Tamoxifen 3件: 2, 113, 227
68 ESR2 2件: Prolactin signaling pathway, Pathways in cancer D11513 Estetrol 1件: 53
69 ESR2 2件: Prolactin signaling pathway, Pathways in cancer D11514 Estetrol 1件: 53
70 F2 4件: Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton, Pathways in cancer D06410 Thrombomodulin Alfa 1件: 85
71 F2 4件: Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton, Pathways in cancer D07144 Dabigatran etexilate 2件: 51, 75
72 F2 4件: Phospholipase D signaling pathway, Platelet activation, Regulation of actin cytoskeleton, Pathways in cancer D09707 Dabigatran 5件: 51, 75, 85, 91, 124
73 FGFR1 9件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton, Pathways in cancer, Proteoglycans in cancer, Prostate cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
74 FGFR1 9件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Thermogenesis, Regulation of actin cytoskeleton, Pathways in cancer, Proteoglycans in cancer, Prostate cancer D11589 Infigratinib 1件: 276
75 FGFR3 6件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
76 FGFR3 6件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer D11589 Infigratinib 1件: 276
77 FGFR2 7件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer D05338 Palifermin 5件: 13, 36, 38, 39, 65
78 FGFR2 7件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
79 FGFR2 7件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer D11589 Infigratinib 1件: 276
80 FLT3 4件: Ras signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer D08524 Sorafenib 2件: 34, 86
81 FLT3 4件: Ras signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer D08552 Sunitinib 2件: 28, 34
82 FLT3 4件: Ras signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer D11270 Pexidartinib 1件: 34
83 FLT4 4件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer D03218 Axitinib 1件: 34
84 FLT4 4件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer D08524 Sorafenib 2件: 34, 86
85 FLT4 4件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer D08552 Sunitinib 2件: 28, 34
86 FLT4 4件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer D08881 Cediranib 1件: 34
87 FLT4 4件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
88 FLT4 4件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer D11772 Tesevatinib 1件: 67
89 ALK 2件: Pathways in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D09731 Crizotinib 1件: 34
90 ALK 2件: Pathways in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10866 Brigatinib 1件: 34
91 MTOR 13件: Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D00753 Sirolimus 40件: 2, 13, 15, 17, 19, 34, 35, 36, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 98, 137, 157, 158, 192, 193, 222, 256, 277, 278, 279, 280, 281, 283, 300, 331
92 MTOR 13件: Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D02714 Everolimus 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277
93 MTOR 13件: Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Shigellosis, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D06068 Temsirolimus 1件: 13
94 ABL1 3件: Ras signaling pathway, Pathways in cancer, Viral myocarditis D03252 Bosutinib 2件: 2, 67
95 ABL1 3件: Ras signaling pathway, Pathways in cancer, Viral myocarditis D03658 Dasatinib 2件: 51, 85
96 ABL1 3件: Ras signaling pathway, Pathways in cancer, Viral myocarditis D06414 Dasatinib 2件: 51, 85
97 ABL1 3件: Ras signaling pathway, Pathways in cancer, Viral myocarditis D08066 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
98 ABL1 3件: Ras signaling pathway, Pathways in cancer, Viral myocarditis D08953 Nilotinib 5件: 6, 8, 34, 51, 86
99 ABL1 3件: Ras signaling pathway, Pathways in cancer, Viral myocarditis D09664 Saracatinib 3件: 6, 89, 272
100 HDAC1 4件: Thyroid hormone signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Viral carcinogenesis D06320 Vorinostat 2件: 75, 96
101 HDAC2 4件: Thyroid hormone signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Viral carcinogenesis D06320 Vorinostat 2件: 75, 96
102 HMOX1 2件: Porphyrin metabolism, Pathways in cancer D05922 Stannsoporfin 1件: 254
103 IFNA1 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09662 Rontalizumab 1件: 49
104 IFNA1 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09668 Sifalimumab 1件: 49
105 IFNA2 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09662 Rontalizumab 1件: 49
106 IFNA2 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09668 Sifalimumab 1件: 49
107 IFNA4 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09662 Rontalizumab 1件: 49
108 IFNA4 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09668 Sifalimumab 1件: 49
109 IFNA5 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09662 Rontalizumab 1件: 49
110 IFNA5 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09668 Sifalimumab 1件: 49
111 IFNA6 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09662 Rontalizumab 1件: 49
112 IFNA6 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09668 Sifalimumab 1件: 49
113 IFNA7 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09662 Rontalizumab 1件: 49
114 IFNA7 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09668 Sifalimumab 1件: 49
115 IFNA8 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09662 Rontalizumab 1件: 49
116 IFNA8 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09668 Sifalimumab 1件: 49
117 IFNA10 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09662 Rontalizumab 1件: 49
118 IFNA10 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09668 Sifalimumab 1件: 49
119 IFNA13 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09662 Rontalizumab 1件: 49
120 IFNA13 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09668 Sifalimumab 1件: 49
121 IFNA14 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09662 Rontalizumab 1件: 49
122 IFNA14 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09668 Sifalimumab 1件: 49
123 IFNA16 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09662 Rontalizumab 1件: 49
124 IFNA16 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09668 Sifalimumab 1件: 49
125 IFNA17 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09662 Rontalizumab 1件: 49
126 IFNA17 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09668 Sifalimumab 1件: 49
127 IFNA21 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09662 Rontalizumab 1件: 49
128 IFNA21 5件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Tuberculosis, Pathways in cancer D09668 Sifalimumab 1件: 49
129 IFNAR1 3件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Pathways in cancer D00745 Interferon alfa-2a 1件: 56
130 IFNAR1 3件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Pathways in cancer D00746 Interferon beta-1b 1件: 13
131 IFNAR1 3件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Pathways in cancer D02745 Interferon alfa-2b 2件: 25, 34
132 IFNAR1 3件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Pathways in cancer D03305 Interferon alfa 6件: 13, 25, 26, 28, 56, 96
133 IFNAR1 3件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Pathways in cancer D04554 Interferon beta-1a 4件: 13, 26, 96, 97
134 IFNAR1 3件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Pathways in cancer D10483 Peginterferon beta-1a 1件: 13
135 IFNAR1 3件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Pathways in cancer D11082 Anifrolumab 3件: 46, 49, 53
136 IFNAR2 3件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Pathways in cancer D00745 Interferon alfa-2a 1件: 56
137 IFNAR2 3件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Pathways in cancer D00746 Interferon beta-1b 1件: 13
138 IFNAR2 3件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Pathways in cancer D02745 Interferon alfa-2b 2件: 25, 34
139 IFNAR2 3件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Pathways in cancer D03305 Interferon alfa 6件: 13, 25, 26, 28, 56, 96
140 IFNAR2 3件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Pathways in cancer D04554 Interferon beta-1a 4件: 13, 26, 96, 97
141 IFNAR2 3件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Pathways in cancer D10483 Peginterferon beta-1a 1件: 13
142 IFNAR2 3件: PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Pathways in cancer D11082 Anifrolumab 3件: 46, 49, 53
143 IFNG 12件: Proteasome, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Pathways in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Systemic lupus erythematosus, Rheumatoid arthritis D04242 Fontolizumab 1件: 46
144 IFNG 12件: Proteasome, TGF-beta signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Type I diabetes mellitus, Toxoplasmosis, Tuberculosis, Pathways in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer, Systemic lupus erythematosus, Rheumatoid arthritis D11120 Emapalumab 3件: 49, 65, 107
145 IFNGR1 6件: Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Pathways in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D00747 Interferon gamma-1b 7件: 18, 65, 85, 228, 299, 301, 326
146 IFNGR2 6件: Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Pathways in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D00747 Interferon gamma-1b 7件: 18, 65, 85, 228, 299, 301, 326
147 IGF1R 9件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Progesterone-mediated oocyte maturation, Pathways in cancer, Transcriptional misregulation in cancer, Proteoglycans in cancer, Prostate cancer D03297 Mecasermin 6件: 65, 78, 96, 168, 265, 299
148 IGF1R 9件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Progesterone-mediated oocyte maturation, Pathways in cancer, Transcriptional misregulation in cancer, Proteoglycans in cancer, Prostate cancer D09680 Teprotumumab 1件: 51
149 IGF1R 9件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Progesterone-mediated oocyte maturation, Pathways in cancer, Transcriptional misregulation in cancer, Proteoglycans in cancer, Prostate cancer D09925 Linsitinib 1件: 232
150 IL2RA 5件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Pathways in cancer D00748 Aldesleukin 6件: 2, 35, 49, 65, 96, 97
151 IL2RA 5件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Pathways in cancer D03058 Basiliximab 6件: 2, 50, 66, 97, 222, 228
152 IL2RA 5件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Pathways in cancer D03639 Daclizumab 8件: 13, 56, 60, 65, 97, 107, 283, 284
153 IL2RB 6件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Pathways in cancer, Transcriptional misregulation in cancer D00748 Aldesleukin 6件: 2, 35, 49, 65, 96, 97
154 IL2RG 6件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Pathways in cancer, Primary immunodeficiency D00748 Aldesleukin 6件: 2, 35, 49, 65, 96, 97
155 IL4 5件: PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, Pathways in cancer D03117 Binetrakin 1件: 46
156 IL4R 4件: PI3K-Akt signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Pathways in cancer D10354 Dupilumab 5件: 51, 97, 98, 160, 162
157 IL5 3件: Th1 and Th2 cell differentiation, T cell receptor signaling pathway, Pathways in cancer D04923 Mepolizumab 4件: 44, 45, 98, 162
158 IL5 3件: Th1 and Th2 cell differentiation, T cell receptor signaling pathway, Pathways in cancer D08985 Reslizumab 2件: 44, 98
159 IL5RA 1件: Pathways in cancer D09874 Benralizumab 5件: 44, 45, 98, 162, 299
160 IL6 14件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Pertussis, Yersinia infection, Tuberculosis, Pathways in cancer, Transcriptional misregulation in cancer, Rheumatoid arthritis D01583 Pirfenidone 11件: 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228
161 IL6 14件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Pertussis, Yersinia infection, Tuberculosis, Pathways in cancer, Transcriptional misregulation in cancer, Rheumatoid arthritis D08976 Pomalidomide 5件: 28, 51, 85, 227, 331
162 IL6 14件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Pertussis, Yersinia infection, Tuberculosis, Pathways in cancer, Transcriptional misregulation in cancer, Rheumatoid arthritis D09669 Siltuximab 2件: 28, 331
163 IL6 14件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Pertussis, Yersinia infection, Tuberculosis, Pathways in cancer, Transcriptional misregulation in cancer, Rheumatoid arthritis D10080 Sirukumab 2件: 41, 46
164 IL6 14件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, Th17 cell differentiation, TNF signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Pertussis, Yersinia infection, Tuberculosis, Pathways in cancer, Transcriptional misregulation in cancer, Rheumatoid arthritis D12487 Olokizumab 2件: 46, 96
165 IL6R 4件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th17 cell differentiation, Pathways in cancer D02596 Tocilizumab 21件: 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 266, 271, 331
166 IL6R 4件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th17 cell differentiation, Pathways in cancer D10161 Sarilumab 5件: 41, 46, 84, 107, 271
167 IL6R 4件: Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Th17 cell differentiation, Pathways in cancer D11079 Satralizumab 3件: 11, 13, 86
168 IL12A 8件: Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Type I diabetes mellitus, Pertussis, Toxoplasmosis, Tuberculosis, Pathways in cancer D09214 Ustekinumab 16件: 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271
169 IL12B 9件: Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Type I diabetes mellitus, Pertussis, Toxoplasmosis, Tuberculosis, Pathways in cancer, Proteoglycans in cancer D09214 Ustekinumab 16件: 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271
170 IL13 2件: Th1 and Th2 cell differentiation, Pathways in cancer D08857 Anrukinzumab 1件: 97
171 IL13 2件: Th1 and Th2 cell differentiation, Pathways in cancer D09633 Lebrikizumab 1件: 85
172 IL13 2件: Th1 and Th2 cell differentiation, Pathways in cancer D09979 Tralokinumab 2件: 85, 97
173 AR 2件: Pathways in cancer, Prostate cancer D00075 Testosterone 8件: 1, 2, 3, 13, 60, 76, 78, 113
174 AR 2件: Pathways in cancer, Prostate cancer D00289 Danazol 5件: 60, 63, 64, 65, 285
175 AR 2件: Pathways in cancer, Prostate cancer D00444 Stanozolol 1件: 60
176 AR 2件: Pathways in cancer, Prostate cancer D00462 Oxandrolone 2件: 211, 285
177 AR 2件: Pathways in cancer, Prostate cancer D00586 Flutamide 1件: 81
178 AR 2件: Pathways in cancer, Prostate cancer D00955 Nandrolone decanoate 2件: 60, 85
179 AR 2件: Pathways in cancer, Prostate cancer D00958 Testosterone enanthate 1件: 113
180 AR 2件: Pathways in cancer, Prostate cancer D00959 Testosterone propionate 1件: 113
181 AR 2件: Pathways in cancer, Prostate cancer D03338 Calusterone 1件: 2
182 AR 2件: Pathways in cancer, Prostate cancer D06087 Testosterone undecanoate 2件: 13, 60
183 AR 2件: Pathways in cancer, Prostate cancer D08250 Nandrolone 2件: 60, 85
184 AR 2件: Pathways in cancer, Prostate cancer D08409 Prasterone 6件: 49, 53, 83, 86, 96, 113
185 AR 2件: Pathways in cancer, Prostate cancer D08573 Testosterone decanoate 1件: 113
186 AR 2件: Pathways in cancer, Prostate cancer D08574 Testosterone phenylpropionate 1件: 113
187 JAK1 9件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Pathways in cancer, Viral carcinogenesis, PD-L1 expression and PD-1 checkpoint pathway in cancer D09959 Ruxolitinib 3件: 60, 65, 228
188 JAK1 9件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Pathways in cancer, Viral carcinogenesis, PD-L1 expression and PD-1 checkpoint pathway in cancer D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
189 JAK1 9件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Pathways in cancer, Viral carcinogenesis, PD-L1 expression and PD-1 checkpoint pathway in cancer D10308 Baricitinib 13件: 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325
190 JAK1 9件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Pathways in cancer, Viral carcinogenesis, PD-L1 expression and PD-1 checkpoint pathway in cancer D10653 Peficitinib 1件: 46
191 JAK1 9件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Pathways in cancer, Viral carcinogenesis, PD-L1 expression and PD-1 checkpoint pathway in cancer D10871 Filgotinib 6件: 46, 53, 96, 97, 222, 271
192 JAK1 9件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Pathways in cancer, Viral carcinogenesis, PD-L1 expression and PD-1 checkpoint pathway in cancer D10944 Itacitinib 4件: 46, 51, 97, 228
193 JAK1 9件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Pathways in cancer, Viral carcinogenesis, PD-L1 expression and PD-1 checkpoint pathway in cancer D10994 Upadacitinib 8件: 40, 41, 46, 49, 96, 97, 107, 271
194 JAK1 9件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Pathways in cancer, Viral carcinogenesis, PD-L1 expression and PD-1 checkpoint pathway in cancer D11400 Abrocitinib 1件: 84
195 JAK2 9件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis, Pathways in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D09959 Ruxolitinib 3件: 60, 65, 228
196 JAK2 9件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis, Pathways in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
197 JAK2 9件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis, Pathways in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10308 Baricitinib 13件: 2, 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 269, 325
198 JAK2 9件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Prolactin signaling pathway, Toxoplasmosis, Tuberculosis, Pathways in cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10653 Peficitinib 1件: 46
199 JAK3 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Pathways in cancer, Viral carcinogenesis, Primary immunodeficiency D09970 Tofacitinib 15件: 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 271, 300
200 JAK3 7件: PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Pathways in cancer, Viral carcinogenesis, Primary immunodeficiency D10653 Peficitinib 1件: 46
201 KIT 5件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer D03658 Dasatinib 2件: 51, 85
202 KIT 5件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer D06414 Dasatinib 2件: 51, 85
203 KIT 5件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer D08066 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
204 KIT 5件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer D08524 Sorafenib 2件: 34, 86
205 KIT 5件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer D08552 Sunitinib 2件: 28, 34
206 KIT 5件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer D08953 Nilotinib 5件: 6, 8, 34, 51, 86
207 KIT 5件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer D10229 Masitinib 6件: 2, 5, 6, 13, 46, 96
208 KIT 5件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer D11270 Pexidartinib 1件: 34
209 MET 7件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Proteoglycans in cancer, Renal cell carcinoma D10062 Cabozantinib 1件: 34
210 NFE2L2 2件: Protein processing in endoplasmic reticulum, Pathways in cancer D10964 Omaveloxolone 1件: 18
211 NFKB1 24件: Ras signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Prolactin signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Pathways in cancer, Transcriptional misregulation in cancer, Viral carcinogenesis, Prostate cancer, Small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D01146 Iguratimod 5件: 46, 51, 53, 271, 300
212 IL23A 5件: Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Rheumatoid arthritis D09214 Ustekinumab 16件: 37, 40, 41, 46, 49, 50, 56, 65, 84, 93, 96, 97, 160, 162, 269, 271
213 IL23A 5件: Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Rheumatoid arthritis D10400 Tildrakizumab 2件: 162, 271
214 IL23A 5件: Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Rheumatoid arthritis D10438 Guselkumab 5件: 37, 41, 51, 96, 97
215 IL23A 5件: Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Rheumatoid arthritis D10912 Brazikumab 2件: 96, 97
216 IL23A 5件: Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Rheumatoid arthritis D11052 Risankizumab 4件: 37, 96, 97, 271
217 IL23A 5件: Th17 cell differentiation, Pertussis, Tuberculosis, Pathways in cancer, Rheumatoid arthritis D11123 Mirikizumab 3件: 37, 96, 97
218 PDGFRA 7件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer D08066 Imatinib 12件: 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162
219 PDGFRA 7件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer D08552 Sunitinib 2件: 28, 34
220 PDGFRA 7件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer D08953 Nilotinib 5件: 6, 8, 34, 51, 86
221 PDGFRA 7件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
222 PDGFRB 7件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer D03658 Dasatinib 2件: 51, 85
223 PDGFRB 7件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer D06414 Dasatinib 2件: 51, 85
224 PDGFRB 7件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer D08524 Sorafenib 2件: 34, 86
225 PDGFRB 7件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer D08552 Sunitinib 2件: 28, 34
226 PDGFRB 7件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer D08953 Nilotinib 5件: 6, 8, 34, 51, 86
227 PDGFRB 7件: Ras signaling pathway, Rap1 signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer D10481 Nintedanib 5件: 51, 85, 89, 227, 228
228 PGF 4件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer D09574 Aflibercept 2件: 90, 166
229 PIK3CA 32件: Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11011 Alpelisib 1件: 138
230 PIK3CA 32件: Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11158 Leniolisib 2件: 53, 65
231 PIK3CB 32件: Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11158 Leniolisib 2件: 53, 65
232 PIK3CD 32件: Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11158 Leniolisib 2件: 53, 65
233 PIK3CD 32件: Platinum drug resistance, Ras signaling pathway, Rap1 signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Regulation of lipolysis in adipocytes, Relaxin signaling pathway, Type II diabetes mellitus, Spinocerebellar ataxia, Prion disease, Shigellosis, Salmonella infection, Yersinia infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11437 Parsaclisib 3件: 35, 53, 61
234 PML 3件: Ubiquitin mediated proteolysis, Pathways in cancer, Transcriptional misregulation in cancer D00094 Tretinoin 6件: 2, 62, 63, 75, 94, 231
235 PPARG 5件: PPAR signaling pathway, Thermogenesis, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer D08378 Pioglitazone 17件: 2, 6, 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299
236 PPARG 5件: PPAR signaling pathway, Thermogenesis, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer D08491 Rosiglitazone 5件: 46, 75, 97, 222, 265
237 PPARG 5件: PPAR signaling pathway, Thermogenesis, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer D11256 Seladelpar 2件: 93, 94
238 PPARG 5件: PPAR signaling pathway, Thermogenesis, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer D11603 Leriglitazone 1件: 20
239 PPARG 5件: PPAR signaling pathway, Thermogenesis, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer D12242 Bocidelpar 1件: 113
240 PRKCB 16件: Ras signaling pathway, Rap1 signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, VEGF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Salivary secretion, Spinocerebellar ataxia, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Proteoglycans in cancer D11935 Enzastaurin 1件: 168
241 MAP2K1 26件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D09666 Selumetinib 1件: 34
242 MAP2K1 26件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10175 Trametinib 4件: 2, 34, 279, 280
243 MAP2K1 26件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10405 Cobimetinib 1件: 280
244 MAP2K1 26件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10604 Binimetinib 1件: 34
245 MAP2K1 26件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, TNF signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11675 Mirdametinib 1件: 34
246 MAP2K2 23件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D09666 Selumetinib 1件: 34
247 MAP2K2 23件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10175 Trametinib 4件: 2, 34, 279, 280
248 MAP2K2 23件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10405 Cobimetinib 1件: 280
249 MAP2K2 23件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D10604 Binimetinib 1件: 34
250 MAP2K2 23件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, Toll-like receptor signaling pathway, T cell receptor signaling pathway, Regulation of actin cytoskeleton, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D11675 Mirdametinib 1件: 34
251 PTGER1 1件: Pathways in cancer D00180 Alprostadil 2件: 51, 70
252 PTGER1 1件: Pathways in cancer D02722 Limaprost 1件: 70
253 PTGER2 2件: Renin secretion, Pathways in cancer D00419 Misoprostol 3件: 46, 70, 271
254 PTGER3 2件: Regulation of lipolysis in adipocytes, Pathways in cancer D00419 Misoprostol 3件: 46, 70, 271
255 PTGER4 2件: Renin secretion, Pathways in cancer D00419 Misoprostol 3件: 46, 70, 271
256 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D00109 Acetylsalicylic acid 14件: 13, 22, 46, 49, 51, 58, 64, 86, 97, 113, 158, 210, 231, 251
257 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D00118 Naproxen 4件: 13, 46, 107, 271
258 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D00120 Sulindac 1件: 206
259 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D00126 Ibuprofen 7件: 13, 46, 65, 107, 113, 271, 299
260 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D00130 Diflunisal 1件: 28
261 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D00132 Ketoprofen 1件: 46
262 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D00141 Indomethacin 3件: 225, 271, 298
263 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D00217 Acetaminophen 15件: 3, 6, 11, 13, 34, 35, 46, 49, 51, 70, 86, 222, 256, 271, 337
264 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D00315 Etodolac 1件: 46
265 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D00330 Flurbiprofen 3件: 13, 21, 46
266 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D00428 Salsalate 1件: 5
267 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D00567 Celecoxib 10件: 2, 3, 34, 46, 70, 89, 107, 161, 171, 271
268 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D00568 Rofecoxib 1件: 46
269 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D00969 Meloxicam 4件: 46, 49, 271, 296
270 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D01049 Nimesulide 1件: 46
271 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D01183 Tolfenamic acid 1件: 5
272 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D01545 Aceclofenac 1件: 46
273 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D02709 Valdecoxib 1件: 46
274 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D03710 Etoricoxib 2件: 46, 271
275 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D03714 Lumiracoxib 1件: 46
276 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D03716 Parecoxib 2件: 46, 271
277 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D07816 Diclofenac 5件: 13, 34, 46, 78, 271
278 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D08104 Ketorolac 2件: 70, 226
279 PTGS2 8件: VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Regulation of lipolysis in adipocytes, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Small cell lung cancer D08149 Loxoprofen 2件: 46, 271
280 RAF1 23件: Ras signaling pathway, Rap1 signaling pathway, Sphingolipid signaling pathway, Phospholipase D signaling pathway, PI3K-Akt signaling pathway, Vascular smooth muscle contraction, VEGF signaling pathway, Signaling pathways regulating pluripotency of stem cells, T cell receptor signaling pathway, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Thyroid hormone signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Salmonella infection, Tuberculosis, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D08524 Sorafenib 2件: 34, 86
281 RARA 3件: Th17 cell differentiation, Pathways in cancer, Transcriptional misregulation in cancer D00094 Tretinoin 6件: 2, 62, 63, 75, 94, 231
282 RARA 3件: Th17 cell differentiation, Pathways in cancer, Transcriptional misregulation in cancer D00348 Isotretinoin 4件: 36, 39, 159, 160
283 RARA 3件: Th17 cell differentiation, Pathways in cancer, Transcriptional misregulation in cancer D01418 Tamibarotene 2件: 26, 96
284 RARA 3件: Th17 cell differentiation, Pathways in cancer, Transcriptional misregulation in cancer D02754 Acitretin 1件: 37
285 RARA 3件: Th17 cell differentiation, Pathways in cancer, Transcriptional misregulation in cancer D02815 Alitretinoin 1件: 49
286 RARA 3件: Th17 cell differentiation, Pathways in cancer, Transcriptional misregulation in cancer D04162 Fenretinide 1件: 299
287 RARA 3件: Th17 cell differentiation, Pathways in cancer, Transcriptional misregulation in cancer D06543 Vitamin A 3件: 13, 53, 90
288 RARB 2件: Pathways in cancer, Small cell lung cancer D00094 Tretinoin 6件: 2, 62, 63, 75, 94, 231
289 RARB 2件: Pathways in cancer, Small cell lung cancer D00348 Isotretinoin 4件: 36, 39, 159, 160
290 RARB 2件: Pathways in cancer, Small cell lung cancer D02754 Acitretin 1件: 37
291 RARB 2件: Pathways in cancer, Small cell lung cancer D02815 Alitretinoin 1件: 49
292 RARB 2件: Pathways in cancer, Small cell lung cancer D04162 Fenretinide 1件: 299
293 RARB 2件: Pathways in cancer, Small cell lung cancer D06543 Vitamin A 3件: 13, 53, 90
294 BCL2 12件: Platinum drug resistance, Sphingolipid signaling pathway, Protein processing in endoplasmic reticulum, PI3K-Akt signaling pathway, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Toxoplasmosis, Tuberculosis, Pathways in cancer, Prostate cancer, Small cell lung cancer D10679 Venetoclax 1件: 28
295 RELA 24件: Ras signaling pathway, Sphingolipid signaling pathway, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, T cell receptor signaling pathway, TNF signaling pathway, Prolactin signaling pathway, Relaxin signaling pathway, Pathways of neurodegeneration - multiple diseases, Shigellosis, Salmonella infection, Pertussis, Yersinia infection, Toxoplasmosis, Tuberculosis, Pathways in cancer, Transcriptional misregulation in cancer, Viral carcinogenesis, Prostate cancer, Small cell lung cancer, PD-L1 expression and PD-1 checkpoint pathway in cancer D12181 Edasalonexent 1件: 113
296 RET 2件: Pathways in cancer, Thyroid cancer D08524 Sorafenib 2件: 34, 86
297 RET 2件: Pathways in cancer, Thyroid cancer D08552 Sunitinib 2件: 28, 34
298 ROCK1 10件: Sphingolipid signaling pathway, Vascular smooth muscle contraction, TGF-beta signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Shigellosis, Yersinia infection, Pathways in cancer, Proteoglycans in cancer D07941 Fasudil 4件: 2, 5, 7, 51
299 RXRA 8件: PPAR signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer D02754 Acitretin 1件: 37
300 RXRA 8件: PPAR signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer D02815 Alitretinoin 1件: 49
301 RXRA 8件: PPAR signaling pathway, PI3K-Akt signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer D03106 Bexarotene 2件: 13, 75
302 RXRB 7件: PPAR signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer D02754 Acitretin 1件: 37
303 RXRB 7件: PPAR signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer D02815 Alitretinoin 1件: 49
304 RXRB 7件: PPAR signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer D03106 Bexarotene 2件: 13, 75
305 RXRG 7件: PPAR signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer D02754 Acitretin 1件: 37
306 RXRG 7件: PPAR signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer D02815 Alitretinoin 1件: 49
307 RXRG 7件: PPAR signaling pathway, Th17 cell differentiation, Thyroid hormone signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer D03106 Bexarotene 2件: 13, 75
308 SMO 2件: Pathways in cancer, Proteoglycans in cancer D09992 Vismodegib 1件: 85
309 SMO 2件: Pathways in cancer, Proteoglycans in cancer D10671 Taladegib 1件: 85
310 BRAF 11件: Rap1 signaling pathway, Vascular smooth muscle contraction, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D08524 Sorafenib 2件: 34, 86
311 BRAF 11件: Rap1 signaling pathway, Vascular smooth muscle contraction, Serotonergic synapse, Regulation of actin cytoskeleton, Progesterone-mediated oocyte maturation, Pathways of neurodegeneration - multiple diseases, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Prostate cancer, Thyroid cancer D10064 Dabrafenib 1件: 34
312 TGFB1 9件: TGF-beta signaling pathway, Th17 cell differentiation, Relaxin signaling pathway, Toxoplasmosis, Tuberculosis, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Rheumatoid arthritis D09620 Fresolimumab 3件: 51, 85, 222
313 TGFB2 7件: TGF-beta signaling pathway, Toxoplasmosis, Tuberculosis, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Rheumatoid arthritis D09620 Fresolimumab 3件: 51, 85, 222
314 TGFB3 6件: TGF-beta signaling pathway, Toxoplasmosis, Tuberculosis, Pathways in cancer, Renal cell carcinoma, Rheumatoid arthritis D09620 Fresolimumab 3件: 51, 85, 222
315 VEGFA 9件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Rheumatoid arthritis D05697 Ranibizumab 4件: 34, 166, 227, 301
316 VEGFA 9件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Rheumatoid arthritis D06409 Bevacizumab 6件: 13, 34, 85, 87, 227, 280
317 VEGFA 9件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Relaxin signaling pathway, Pathways in cancer, Proteoglycans in cancer, Renal cell carcinoma, Rheumatoid arthritis D09574 Aflibercept 2件: 90, 166
318 VEGFB 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Relaxin signaling pathway, Pathways in cancer D09574 Aflibercept 2件: 90, 166
319 CXCR4 5件: Viral life cycle - HIV-1, Virion - Human immunodeficiency virus, Viral protein interaction with cytokine and cytokine receptor, Regulation of actin cytoskeleton, Pathways in cancer D08971 Plerixafor 5件: 19, 20, 65, 285, 299
320 FGF23 5件: Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer D10913 Burosumab 1件: 238
321 CASP9 12件: Platinum drug resistance, PI3K-Akt signaling pathway, VEGF signaling pathway, Thyroid hormone signaling pathway, Prion disease, Pathways of neurodegeneration - multiple diseases, Toxoplasmosis, Tuberculosis, Pathways in cancer, Prostate cancer, Small cell lung cancer, Viral myocarditis D11195 Rimiducid 6件: 19, 60, 65, 284, 285, 326
322 ROCK2 11件: Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Shigellosis, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer D07941 Fasudil 4件: 2, 5, 7, 51
323 ROCK2 11件: Sphingolipid signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, Tight junction, Platelet activation, Regulation of actin cytoskeleton, Shigellosis, Salmonella infection, Yersinia infection, Pathways in cancer, Proteoglycans in cancer D11815 Belumosudil 2件: 51, 85
324 KEAP1 2件: Ubiquitin mediated proteolysis, Pathways in cancer D03846 Dimethyl fumarate 5件: 13, 49, 51, 86, 296